1 Min Read
May 4 (Reuters) - Corvus Pharmaceuticals Inc:
* Corvus Pharmaceuticals reports first quarter 2017 financial results and provides business update
* Qtrly loss per share $0.79 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.